Paper

Public Private Partnerships in trust-based public health social networking: Connecting organizations for regional disease surveillance (CORDS)

Public Private Partnerships in trust-based public health social networking: Connecting organizations for regional disease surveillance (CORDS)

Want to dive deeper?

Visit the Education Center

Louise S. Gresham PhD, MPH

Journal of Commercial Biotechnology (2011) Volume 17

Co-authors:  Leslie A Pray, Suwit Wibulpolprasert and Beverly Trayner

The article describes a new trust-based global health security initiative known as CORDS: Connecting Organizations for Regional Disease Surveillance. Initiated and managed by the Nuclear Threat Initiative with support of The Rockefeller Foundation, Fondation Mérieux and the Skoll Global Threats Fund. CORDS is a non-governmental platform to transform dialogue among public health, veterinary and wildlife professionals from multi-country infectious disease surveillance networks. It also links with the World Health Organization, World Organization for Animal Health and other global partners in managing cross-border emerging infectious disease threats and building disease surveillance capacity. The public–private partnerships of CORDS create a global social fabric and continuity of disease experts based upon trust.

Click here for access to the article through the publisher. 

 

Stay Informed

Sign up for our newsletter to get the latest on nuclear and biological threats.

Sign Up

Developing Guardrails for AI Biodesign Tools

Paper

Developing Guardrails for AI Biodesign Tools

The integration of artificial intelligence (AI) with the life sciences offers tremendous potential benefits to society, but advances in AI biodesign tools also pose significant risks of misuse, with the potential for global consequences.


The Convergence of Artificial Intelligence and the Life Sciences

Report

The Convergence of Artificial Intelligence and the Life Sciences

New report from NTI | bio offers recommendations for urgent actions that leaders within government, industry, the scientific community, and civil society should take to safeguard AI-bio capabilities.



Close

My Resources